Correlation Between Anebulo Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Anebulo Pharmaceuticals and Cullinan Oncology
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Anebulo and Cullinan is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 4.89 times less return on investment than Cullinan Oncology. In addition to that, Anebulo Pharmaceuticals is 1.43 times more volatile than Cullinan Oncology LLC. It trades about 0.01 of its total potential returns per unit of risk. Cullinan Oncology LLC is currently generating about 0.05 per unit of volatility. If you would invest 869.00 in Cullinan Oncology LLC on August 25, 2024 and sell it today you would earn a total of 385.00 from holding Cullinan Oncology LLC or generate 44.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Cullinan Oncology LLC |
Anebulo Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Anebulo Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. RenovoRx | Cullinan Oncology vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |